Related Experiment Video
Updated: Apr 12, 2026
MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
MicroRNA-130a Targets MAP3K12 to Modulate Diabetic Endothelial Progenitor Cell Function
Aims:
The aim of the present study was to explore the influence of microRNA (miR)-130a dysregulation on the JNK signal pathway through its target MAP3K12 in diabetic endothelial progenitor cells (EPCs).
Methods:
The expression of miR-130a was compared between diabetic and normal EPCs. Computational target prediction was performed to identify MAP3K12 as a functionally relevant target of miR-130a in EPCs. The role of miR-130a was investigated regarding its anti-apoptotic effects and its role on the regulation of EPC function was evaluated through the negative regulation of the JNK signal pathway
Results:
MiR-130a expression was significantly downregulated in diabetic EPCs, and cell proliferation was reduced in EPCs under high glucose condition. miR-130a inhibited the JNK pathway by targeting MAP3K12, contributing to its anti-apoptotic effect and the maintenance of EPC function. In diabetic EPCs, high glucose affects the expression of miR-130a, inducing sustained JNK activation and promoting EPC apoptosis and dysfunction.
Conclusions:
Downregulation of miR-130a may underlie endothelial dysfunction in diabetes through the activation of JNK signal pathway.
Insights
MicroRNA-130a (miR-130a) downregulation in diabetes impairs endothelial progenitor cell (EPC) function by activating the JNK pathway. Restoring miR-130a levels may protect against diabetic endothelial dysfunction.
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Biology
Background:
- Diabetic complications often involve endothelial dysfunction.
- Endothelial progenitor cells (EPCs) play a crucial role in vascular repair.
- MicroRNAs (miRNAs) are key regulators of cellular processes.
Purpose of the Study:
- To investigate the role of microRNA-130a (miR-130a) in diabetic endothelial progenitor cells (EPCs).
- To determine the impact of miR-130a on the JNK signaling pathway and its target MAP3K12.
- To elucidate the mechanism underlying miR-130a's influence on EPC function in diabetes.
Main Methods:
- Compared miR-130a expression in diabetic and normal EPCs.
- Utilized computational target prediction to identify MAP3K12 as a miR-130a target.
- Assessed miR-130a's anti-apoptotic effects and regulation of EPC function via the JNK pathway.
Main Results:
- miR-130a was significantly downregulated in diabetic EPCs, correlating with reduced cell proliferation.
- miR-130a inhibited the JNK pathway by targeting MAP3K12, preserving EPC function and reducing apoptosis.
- High glucose conditions in diabetes led to sustained JNK activation, promoting EPC apoptosis and dysfunction.
Conclusions:
- Downregulation of miR-130a contributes to endothelial dysfunction in diabetes.
- Activation of the JNK signaling pathway by low miR-130a is a key mechanism.
- Targeting miR-130a may offer a therapeutic strategy for diabetic vascular complications.
